Pictet Asset Management (UK)’s Integra LifeSciences IART Stock Holding History

Pictet Asset Management (UK)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$321K	Sell	4,700 -900	-16%	-$63.6K	﹤0.01%	1392
2021 Q1	$387K	Sell	5,600 -600	-10%	-$40.6K	﹤0.01%	1304
2020 Q4	$403K	Hold	6,200	–	–	﹤0.01%	1241
2020 Q3	$293K	Buy	+6,200	New	+$295K	﹤0.01%	1242

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (UK)'s IART Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Integra LifeSciences (IART) stake by 16% in Q2 2021, selling an estimated $63.6K and leaving 4,700 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Pictet Asset Management (UK) first reported a position in IART in Q3 2020 and has held it in 4 quarters since. The position peaked at $403K in Q4 2020. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

Pictet Asset Management (UK) held 4,700 shares of Integra LifeSciences worth $321K as of Q2 2021.
Pictet Asset Management (UK) sold 900 Integra LifeSciences shares in Q2 2021, an estimated $63.6K.
Integra LifeSciences made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1392 holding.
Pictet Asset Management (UK) first reported a position in Integra LifeSciences in Q3 2020 and has held it in 4 quarters since.
Pictet Asset Management (UK)'s Integra LifeSciences position peaked at $403K in Q4 2020.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.